Vaccine and treatment evaluation units (VTEU) protocol implementation task area C phase 2 vaccine trial for ebola virus task order FY.2018.C3.0091
Ended Awarded Last action
- Contract number
- HHSN27200021
- Awardee
-
Emory University UEI S352L5PJLMP8
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,670,223
Award facts
- Opportunity
-
- NIAIDDMIDNIHAI2012144 Solicitation number
- Vaccine and treatment evaluation units (VTEU) Award Notice · Posted Mar 29, 2012
- Contract value 100% obligated
- $1,670,222.75 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Cost No Fee
- Place of performance
- Atlanta, GA 30322, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$52,039 | |
| Funding Only Action | -$520,000 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $1,197,070 | |
| Supplemental Agreement for work within scope | $508,405 | |
| Original award | $536,787 |
About this award
This federal contract award is for the Vaccine Treatment and Evaluation Units (VTEU) program, which is managed by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH). The contract, valued at $1,670,222.75, was awarded to Emory University, a private research institution in Atlanta, Georgia, to provide services related to the development and evaluation of vaccines and treatments for infectious diseases. The contract is a delivery order under a larger VTEU Indefinite Delivery Contract (IDC). The award does not have a set-aside designation, and the contract performance period extends through May 31, 2024. As a leading academic and research center, Emory University has an extensive track record of conducting federally funded research in the areas of biomedical science, public health, and clinical studies, making them a valuable partner for the NIAID's efforts to advance medical countermeasures against infectious diseases.
Quick answers
Who was awarded contract HHSN27200021?
HHSN27200021 was awarded to Emory University by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on January 3, 2018.
How much is contract HHSN27200021 worth?
The government has obligated $1,670,223 on HHSN27200021.
Is contract HHSN27200021 an order under another contract?
Yes. HHSN27200021 is a delivery order under HHSN272201300018I, an indefinite delivery contract, on Vaccine and Treatment Evaluation Units (VTEU).
Was contract HHSN27200021 competed?
The extent of competition for HHSN27200021 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award